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Abstract
Background: Brachydactyly type E (BDE; MIM#113300) is characterized by shortening of the metacarpal, metatarsal,
and often phalangeal bones, and predominantly affects postaxial ray(s) of the limb. BDE may occur as an isolated
trait or as part of a syndrome. Isolated BDE is rare and in the majority of cases the molecular pathogenesis has so
far not been resolved. Originally, the molecular cause of isolated BDE has been unravelled in 2 families and shown
to result from heterozygous missense mutations in the homeodomain of the HOXD13 gene. Since the initial
manuscript, one further HOXD13 mutation has been reported only in a single family manifesting isolated BDE.
Case Presentation: In this paper, we report on a Polish family exhibiting isolated BDE caused by a novel nonsense
heterozygous HOXD13 mutation. We investigated a Polish female proband and her father, both affected by isolated
BDE, in whom we identified a nonsense heterozygous mutation c.820C > T(p.R274X) in the HOXD13 gene. So far,
only two missense HOXD13 substitutions (p.S308C and p.I314L), localized within the homeodomain of the HOXD13
transcription factor, as well as a single nonsense mutation (p.E181X) were associated with BDE. Both missense
changes were supposed to alter DNA binding affinity of the protein.
Conclusion: The variant p.R274X identified in our proband is the fourth HOXD13 mutation, and the second
truncating (nonsense) mutation, reported to result in typical isolated BDE. We refer our clinical and molecular
findings to the previously described HOXD13 associated phenotypes and mutations.
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Background
Brachydactyly type E (BDE; MIM#113300) is character-
ized by shortening of the metacarpal, metatarsal, and
often phalangeal bones, and predominantly affects post-
axial ray(s) of the limb [1]. In most cases BDE is syndro-
mic and occurs within the clinical spectrum of Turner
syndrome, Albright hereditary osteodystrophy (AHO;
MIM#103580) or 2q37 deletion [1]. Isolated BDE is rare
and in the majority of cases has unknown genetic back-
ground. Originally, the molecular cause of isolated BDE
h a sb e e nu n r a v e l l e di n2f a m i l i e sa n ds h o w nt or e s u l t
from heterozygous missense mutations in the homeodo-
main of the HOXD13 gene [2]. Some patients from
these families presented not only with BDE, but also
with overlapping features of brachydactyly type D
(BDD), defined as shortening and broadening of the
thumbs [2].
Missense variants affecting other residues of the C-
terminal HOXD13 homeodomain may also give rise to
different and more severe limb phenotypes such as syn-
polydactyly (SPD; MIM#186000) or syndactyly type 5
(MIM#186300), whereas expansion or contraction of the
N-terminal HOXD13 polyalanine tract usually results in
SPD [3-6]. Most patients affected by SPD show fusion
of third and fourth fingers and fourth and fifth toes,
accompanied with incomplete or complete insertional
polydactyly within the syndactylous web. Affected indivi-
duals may also have external rotation of fifth toes, clino-
dactyly, and camptodactyly (Figure 1H, I &1J present a
family with classical SPD caused by insertion of 7 ala-
nines within the HOXD13 polyalanine tract). The clini-
cal presentation of SPD is highly heterogeneous and
varies within the affected individual (asymmetrical
expressivity) or in the family. Severe manifestation and
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reproduction in any medium, provided the original work is properly cited.Figure 1 A-Brachydactyly type E (BDE) in the proband characterized by shortened V
th fingers, B, C-Clinical picture of BDE (shortened
V
th fingers and toes) in the proband’s father, D-X-ray of the proband’s hands showing shortening of the V
th right metacarpal,
bilateral shortening and broadening of the I
st metacarpals, and bilateral shortening of the middle phalanges of V
th fingers (skeletal
abnormalities are indicated by the white arrows), E-Feet of the proband showing broad halluces and no clinically evident BDE, F-
Pedigree of the presented BDE family (proband is indicated by an arrow), G-Chromatogram picture showing the c.820C > T(p.R274X)
HOXD13 mutation. Wild-type HOXD13 protein sequence is presented in blue, whereas truncated protein variant is shown in red. H - Hand
malformation typical for synpolydactyly (SPD) spectrum (syndactyly of fingers 3/4 with insertional polydactyly within the syndactylous web), I -
Typical SPD foot malformation characterized by syndactyly of 4/5 toes, J - External rotation of 5
th toe often seen in SPD patients (SPD in patients
shown in pictures H, I, J results from insertions of 7 Ala in the polyalanine tract).
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gree [4,5].
HOXD13 i sam e m b e ro fal a r g ef a m i l yo fd e v e l o p -
mental homeobox transcription factor genes. Human, as
well as other vertebrate genomes contain 39 HOX genes
organized into four clusters (HOXA, HOXB, HOXC, and
HOXD). HOX genes are involved in body plan formation
and embryonic development of many internal organs,
such as central nervous system, gastrointestinal and gen-
itourinary tract. They also play a critical role in limb
development by influencing limb patterning along proxi-
modistal and anteroposterior axes. In general, the posi-
tion of the gene in each cluster corresponds to its
spatio-temporal expression during limb development in
an order from 3’ to 5’ end. Thus, homologues located at
the 3’ end of the cluster are expressed earlier in devel-
opment and in more proximal and anterior structures,
whereas those located at the 5’ end are expressed later
and in more posterior and distal embryonic regions
[7,8]. The HOXD13 gene consists of two exons and
encodes a protein built of 335 amino acids. Exon 1 con-
tains an N-terminal tract comprised of 15 polyalanine
residues in wild-type protein. Exon 2 carries a sequence
for a highly conserved C-terminal DNA binding domain,
known as homeodomain, through which HOXD13 inter-
acts with consensus DNA sequence. A schematic view
of the protein structure and a summary of annotated
mutations are given in Figure 2.
Recently, Klopocki et al. [9] described causative altera-
tions (microdeletion and point mutations) in the
PTHLH gene in five unrelated families affected by BDE
and short stature. Since the initial paper of Johnson et
al. from 2003 [2], HOXD13 mutation has been reported
only in a single family manifesting isolated BDE [10]. In
addition, only 8 out of 24 annotated HOXD13 mutations
resulted in a premature termination of the protein
synthesis [10-17]; see Figure 2). Thus, genotype-pheno-
type correlation for truncating HOXD13 variants
remains poorly known.
In this paper, we relate on a Polish family exhibiting
isolated BDE caused by a nonsense heterozygous
HOXD13 mutation and refer our clinical and molecular
finding to previously described HOXD13 associated phe-
notypes and mutations.
Case presentation
We investigated a 10 year old female proband and her
28 year old father of Polish origin, both affected by iso-
lated BDE (a family tree is shown in Figure 1F). Skeletal
manifestations of the proband (Figure 1A, D &1E) com-
prised shortening of the V
th right metacarpal without
shortening of IV
th metacarpal bones, bilateral shortening
and broadening of the I
st metacarpals, bilateral shor-
tened, trapezoid middle phalanges of V
th fingers
resulting in rather severe clinodactyly, as well as con-
tractures and deviations of the fingers II-IV. Upon clini-
cal examination feet of the proband showed broad
halluces and no clinically recognizable BDE phenotype.
Unfortunately, since no X-ray was available, we were
unable to rule out all possible skeletal foot abnormal-
ities. The proband’s father (Figure 1B &1C) manifested
finger contractures, shortening of the V
th fingers and
toes most probably due to shortened V
th metacarpals
and metatarsal, shortened finger nails of the V
th fingers
most likely resulting from hypoplastic distal phalanges,
as well as short thumbs. Unfortunately, the patient
decided not to undergo X-ray examination, thus we
were unable to delineate skeletal findings in more detail.
Both patients had normal stature and normal psycho-
motor development.
Genomic DNA was extracted from peripheral blood
leukocytes according to salting-out method [18]. The
entire coding sequence of the HOXD13 gene comprised
of two exons and the flanking intronic regions (Gen-
Bank NM_000523.3) were amplified in PCR reactions
and directly sequenced using dye-terminator chemistry
(kit v.3, ABI 3130XL). Sequences of the primers used
for amplification and sequencing PCR reactions are
given in table 1. PCR conditions used for HOXD13
amplification where as follows: 40 cycles, denaturation
in 95°C (30’), annealing (30’) with temperature starting
from 63°C, decreasing to 55°C (touchdown PCR -0.2°C
per cycle), and elongation in 72°C (45’). Multiplex liga-
tion-dependent probe amplification (MLPA) for both
exons of the HOXD13 was performed by means of P179
commercial kit according to the manufacturer’s protocol
(MRC Holland).
The proband and her father carried a nonsense het-
erozygous mutation c.820C > T(p.R274X) in the
HOXD13 gene (Figure 1G). Presence of this mutation
was excluded in 208 ethnically matched control chro-
mosomes. MLPA ruled out intragenic copy number
changes within the HOXD13 in both proband and her
father (i.e. deletion/duplication).
Discussion
S of a r ,o n l yaf e wHOXD13 mutations are known to
result in an isolated brachydactyly phenotype [2,10].
Originally, two missense mutations (p.S308C and p.
I314L), localized within the homeodomain of the
HOXD13 transcription factor were associated with over-
lapping features of BDE and BDD [2]. Both changes
were supposed to alter DNA binding affinity of the pro-
tein [2]. Additionally, one nonsense variant p.E181X was
described by Brison et al. [10] in a Belgian family pre-
senting with isolated BDE, but neither detailed clinical
description nor pictures were provided for this case.
The variant p.R274X identified in our proband and her
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truncating (nonsense) mutation reported to result in
typical isolated BDE/BDD. Noteworthy, clinical manifes-
tation of BDE in our patients shared significant similari-
ties with the features reported by Johnson et al. [2] in
the two original families. In addition to metacarpal bra-
chydactyly (BDE), both ours and Johnson’s patients had
clinodactyly, deviations, and contractions of fingers,
short thumbs with apparently hypoplastic distal pha-
langes, and hypoplastic middle and distal phalanges,
especially of the little fingers. Unlike Johnson’s families,
none of our patients showed syndactyly of 3/4, ring fin-
ger duplication or long distal digit phalanges. Moreover,
metacarpal brachydactyly in our case was confined solely
to V
th digits, whereas in other BDE patients also affected
other rays [1,2].
The mutant HOXD13 protein (p.R274X) synthesized
in our proband is predicted to lack the entire homeodo-
main and hence cannot bind to DNA consensus. Like-
wise, the same pathogenic mechanism most probably
Figure 2 Schematic presentation of the HOXD13 gene structure and overview of all annotated HOXD13 mutations identified in
patients affected by various limb malformations. Arrows indicate approximate positions of HOXD13 mutations. Numbers below or above
each arrow refer to specific mutations and correspond to the numbers provided in the table below. Different designations have been used to
discriminate between types of mutations: arrows above the exons indicate mutations causing BDE, BD-syndactyly, and syndactyly type V (white,
grey, and black arrows respectively); arrows below the exons show mutations resulting in SPD or unspecified limb phenotype (black and grey
arrows respectively). Mutation p.R274X identified in our proband (number 18) has been bolded and highlighted with large arrow.
Table 1 Sequences of the primers used for HOXD13 gene amplification and sequencing.
Exon name
(fragment)
Forward primer sequence 5’-3 ’ Reverse primer sequence 5’-3 ’ Product size
(bp)
HOXD13_e1(a) TATAAACGTCCCGCGATGAG ATTCTGCTGTAAGCCCACGC 644
HOXD13_e1(b) CAAAGAGTGCCCAGCACC TAACCCTGGTCACGTGTGG 599
HOXD13_e2 AAAATTTCCTGCACCCCTG CACAAAATTTGCCACCATTG 491
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in isolated BDE (see Figure 2). On the other hand, the
most terminal of all known truncating HOXD13 muta-
tion (p.R319X), which is localized at the very end of the
homeodomain sequence, produces SPD. Out of truncat-
ing HOXD13 alterations, four frameshift and one spli-
cing mutation have been additionally described in the
literature. Four of them caused a phenotype referred to
as “SPD with foot anomalies” (MIM#186000), in which
classic SPD was accompanied by supernumerary digit
between I
st-II
nd and often IV
th-V
th metatarsals [16,17].
The most plausible mechanism through which all trun-
cating mutations exert their pathogenic effect is func-
tional haploinsufficiency of HOXD13. Conversely,
missense substitutions affecting different residues of
homeodomain alter rather than abolish DNA binding
ability of the mutant protein. Hence, mixed both gain-
and loss-of-function mechanisms have been postulated
to account for different limb phenotypes associated with
these mutations [2,6]. Despite different mutational
mechanisms of p.I314L and p.S308C substitutions in
reference to our mutation (p.R274X), there has been a
substantial overlap in the clinical phenotype. More
severe presentation associated with missense mutations
can be thus explained by their dominant-negative effect.
Another example of a homeotic gene known from its
pleiotropic pathogenic effect is a HOXD13 paralogue
belonging to a HOXA cluster-HOXA13. Mutations in
this gene may give rise to different phenotypes, depend-
ing on their type and intragenic location. While non-
sense truncating mutations N-terminal to or within the
homeodomain, as well as expansions of polyalanine tract
cause Hand-foot-genital syndrome (HFGS also known
as Hand-foot-uterus syndrome; HFUS; MIM#140000),
missense mutation within the homeodomain has been
associated with Guttmacher syndrome (MIM #176305),
a phenotype in which HFGS features are accompanied
with postaxial polydactyly of the hands and uniphalan-
geal second toes [19,20].
In the developmental context, Hoxd13 has been shown
to suppress chondrogenesis in the interdigital space,
thus being responsible for proper digit formation. A
loss-of-function mutation in mouse Hoxd13 results in
down-regulation of Raldh2 and thereby in low tissue
concentration of retinoic acid. This induces expression
of Sox9 in the interdigital mesenchyme, the formation of
interdigital condensation, and consequently, polydactyly
[21]. Conversely, missense mutations of human
HOXD13 localized in the homeodomain exert their
pathogenicity via gain-of-function effect that possibly
reduces level of SOX9 expression. Of note, Sox9 is also
a target molecule of Pthlh (Pthrp) signaling in prehyper-
trophic chondrocytes in the growth plate. Pthlh
increases transcriptional activity of Sox9,h e l p st o
maintain chondrocyte phenotype of the cells in the pre-
hypertrophic zone, and inhibits their differentiation to
hypertrophic chondrocytes [22]. Hence, haploinsuffi-
ciency of human PTHLH in BDE patients may at least
partly result in reduced transcriptional activity of SOX9,
which fails to maintain the chondrocyte phenotype in
prehypertrophic zone and, in turn, promotes their
maturation to hypertrophic chondrocytes.
Conclusions
Isolated BDE can be caused by either HOXD13 non-
sense mutations or missense substitutions within the
homeodomain of the HOXD13 transcription factor.
HOXD13 is a pleiotropic gene associated with various
limb malformations. Most of the mutations occurring
within the gene produce SPD, and not BDE.
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